Tag: Bladder Infections
Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome
Sustained response seen up to six months after injection
Biomarkers + Patient-Reported Outcomes Up Prediction of Interstitial Cystitis
Area under the curve higher for biomarker measurements and patient-reported outcomes versus outcomes or biomarkers alone
Obstructive Sleep Apnea Linked to Bladder Pain/Interstitial Cystitis
Women with OSA have higher median Interstitial Cystitis Symptom Index, Interstitial Cystitis Problem Index
No Significant Increase Seen in Cystitis Diagnoses During COVID-19 Pandemic
More women diagnosed with interstitial cystitis/bladder pain syndrome, but difference was not significant
COVID-19 Tied to Higher Risk for New, Worsening Bladder Symptoms
Symptomatic infection tied to three times greater risk for developing new or worsening overactive bladder symptoms
Donepezil Tied to Risk for Overactive Bladder
Risk for overactive bladder varies across individual cholinesterase inhibitor drugs
Better UTI Monitoring Needed After Hospital Admission in Adults
Many healthcare-associated, community-onset urinary tract infections develop after being discharged
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
